International Union of Pharmacology. XXXIII. Mammalian γ-Aminobutyric AcidB Receptors: Structure and Function

  title={International Union of Pharmacology. XXXIII. Mammalian $\gamma$-Aminobutyric AcidB Receptors: Structure and Function},
  author={Norman G. Bowery and Bernhard Bettler and Wolfgang Froestl and Joel P. Gallagher and Fiona H Marshall and Maurizio Raiteri and Tom I. Bonner and Sam J. Enna},
  journal={Pharmacological Reviews},
  pages={247 - 264}
The γ-aminobutyric acidB(GABAB) receptor was first demonstrated on presynaptic terminals where it serves as an autoreceptor and also as a heteroreceptor to influence transmitter release by suppressing neuronal Ca2+ conductance. Subsequent studies showed the presence of the receptor on postsynaptic neurones where activation produces an increase in membrane K+ conductance and associated neuronal hyperpolarization. (−)-Baclofen is a highly selective agonist for GABAB receptors, whereas the… 

Figures and Tables from this paper

Clinical potential of GABAB receptor modulators.

A new class of phenylalkylamines are presented, based on the lead compound fendiline, that are potent positive potentiators of GABAB receptor-mediated function and discussed their putative clinical applications.

Exploring the activity of an inhibitory neurosteroid at GABAA receptors

It is shown that the inhibitory neurosteroid pregnenolone sulphate directly modulates GABAA receptor kinetics by speeding up current decay at both neuronal and recombinant receptors.

Allosteric Modulators of GABAB Receptors: Mechanism of Action and Therapeutic Perspective

It is shown that, as expected, these molecules have more pronounced in vivo responses and less side effects than pure agonists, offering new potential therapeutic applications for this new class of GABAB ligands.

GABA(B) receptors: structure and function.

  • P. Emson
  • Biology
    Progress in brain research
  • 2007

Structural mechanism of ligand activation in human GABAB receptor

Human GABAB (γ-aminobutyric acid class B) receptor is a G-protein-coupled receptor central to inhibitory neurotransmission in the brain. It functions as an obligatory heterodimer of the subunits GBR1

Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling

  • M. Terunuma
  • Biology, Chemistry
    Proceedings of the Japan Academy. Series B, Physical and biological sciences
  • 2018
The structure, subunit isoforms, and function of GABAB receptors are summarized, including how receptors are localized in specific subcellular compartments, the mechanism regulating cell surface expression and mobility of the receptors, and the diversity of receptor signaling through receptor crosstalk and interacting proteins are discussed.

Suppressive Effect of γ-Aminobutyric Acid (GABA) on Histamine Release in Rat Basophilic RBL-2H3 Cells

The inhibitory eff ect of GABA on histamine release in rat basophilic RBL-2H3 cells was examined to examine whether GABAmediated inhibition of tracheal contractions is directly due to inhibition of histamines release in mast cells.

Molecular mechanisms of metabotropic GABAB receptor function

These discoveries provide comprehensive insights into the activation of the GABAB receptor, which not only broaden the understanding of its structure, pharmacology, and physiological effects but also will ultimately facilitate the discovery of new therapeutic drugs and neuromodulators.



Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex.

The aim of this work was the identification of pharmacologically distinct subtypes of gamma-aminobutyric acidB (GABAB) receptors in the central nervous system by choosing as models the GABAB receptors mediating inhibition of release of endogenous GABA; 2) endogenous glutamate; and 3) somatostatin-like immunoreactivity (SRIF-LI).

gamma-aminobutyric acid(B) receptors: first of the functional metabotropic heterodimers.

  • N. BoweryS. Enna
  • Biology
    The Journal of pharmacology and experimental therapeutics
  • 2000
Besides being the first example of a functional heterodiameric metabotropic receptor, the components and molecular configuration of the GABA(B) receptor suggest novel mechanisms for producing pharmacologically distinct subtypes of G protein-coupled receptors.

GABAB-receptor subtypes assemble into functional heteromeric complexes

A new GABAB receptor subtype is described, GABABR2, which does not bind available GABAB antagonists with measurable potency and exhibits a significant increase in agonist- and partial-agonist-binding potencies as compared with individual receptors.

(–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor

GABA clearly decreased the evoked release of accumulated 3H-noradrenaline from rat atria in vitro and3H-acetylcholine from preganglionic terminals in the rat superior cervical ganglion in vitro without affecting the basal release of tritium.

GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2

It is shown that co-expression of two GPCR structures, GABABR1 and GABABR2, belonging to the samesubfamily is essential for signal transduction by GABAB receptors.

Intracellular Retention of Recombinant GABABReceptors*

It is reported that recombinant GABAB receptors fail to reach the cell surface when expressed in heterologous systems and are retained in the endoplasmic reticulum when introduced into COS cells and proved that they fail to activate in superior cervical ganglion neurons.

gamma-aminobutyric acid type B receptors are expressed and functional in mammalian cardiomyocytes.

Electrophysiological evidence is provided that GHB activates an inwardly rectifying K(+) current in rat ventricular myocytes, which concludes that GABA(B)Rs are distributed not only in neuronal tissues but also in the heart, where they can be activated and induce electrophysiology alterations through G-protein-coupled inward rectifier potassium channels.

Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.

In exploring GABA and baclofen derivatives by replacing the carboxylic acid residue with various phosphinic acid groups, more potent and water soluble GABAB antagonists were discovered, suggesting potential cognition enhancing effects.

Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor.

  • O. Snead
  • Biology, Psychology
    Journal of neurochemistry
  • 2000
The hypothesis that GHB induces a Gprotein-mediated decrease in adenylyl cyclase via a GHB-specific G protein-coupled presynaptic receptor that is different from the GABA(B)R was tested and supported.

GABAB receptor agonists and antagonists: pharmacological properties and therapeutic possibilities.

  • S. Enna
  • Biology
    Expert opinion on investigational drugs
  • 1997
Preclinical results indicate that, in addition to their established use as muscle relaxants, GABAB receptor agonists possess analgesic and antitussive properties, and may be useful for treating bladder dysfunction, and while there is less clinical data on GABAB receptors antagonists, preclinical results indicates that they may be of value in treating absence epilepsy, cognitive dysfunction and, possibly, pulmonary and intestinal disorders.